RT @ThomasCiullaMD: Pleased by the FDA’s acceptance of our IND for CLS-AX (axiti…
[ad_1]
RT @ThomasCiullaMD: Pleased by the FDA’s acceptance of our IND for CLS-AX (axitinib injectable suspension), enabling initiation of a Phase…
[ad_2]
Source by Thomas Ciulla, MD, MBA